LinkedIn Network Updates, 11/20/2012

	LinkedIn Network Updates, Nov 13 - Nov 20 Updates from Your Extended Network Connect with them to see what they're up to Matt Boeckeler http://lnkd.in/wF3Pi8 After FDA rejection, Bristol-AstraZeneca team wins E.C. OK for... AstraZeneca and Bristol-Myers Squibb were stiff-armed by the FDA on their application for the SGLT2 diabetes drug dapagliflozin, but European regulators believe the benefits outweighed the risks that pushed the agency to reject... Connect with Matt · Comment Stephen Kanes http://lnkd.in/Wpy-YD Pharm Exec's 2013 Pipeline Report Is the "lost decade" of declining pipeline productivity finally over? Our annual survey of analyst assessments of the state of drug development suggests so, with subtle shards of sunlight beginning to penetrate the gloom cast... Connect with Stephen · Comment Athula Herath 7 Venn -- Now you see it (then you did not)! http://lnkd.in/99jRhb Art of Statistics 7-VENN-COLOUR-BLEND ... David McCandless' post on his Information is Beautiful site (as noted below) prompted me to assign a colour to each of the 7 shapes ... ROY.G.BIV ... Red, Orange, Yellow, Green, Indigo, Violet (with 40%... Connect with Athula · Comment Rikard Thulin http://lnkd.in/Hrn9gi Devoxx 2012 Så var det dags för Devoxx 2012 (tidigare JavaPolis) som är en europeisk Java, Android och HTML5 konferens. Konferensen hålls varje år i Belgien. Under... Connect with Rikard · Comment View All Updates
	You are receiving Network Updates emails. Unsubscribe. This email was intended for start292 almar (aasdfsdfsd at AstraZeneca). Learn why we included this. © 2012, LinkedIn Corporation. 2029 Stierlin Ct. Mountain View, CA 94043, USA